- Home
- ACNB vs TERN Comparison
ACNB vs TERN Comparison
Compare ACNB & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- TERN
- Stock Information
- Founded
- ACNB 1857
- TERN 2017
- Country
- ACNB United States
- TERN United States
- Employees
- ACNB N/A
- TERN N/A
- Industry
- ACNB Major Banks
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- ACNB Finance
- TERN Health Care
- Exchange
- ACNB Nasdaq
- TERN Nasdaq
- Market Cap
- ACNB 331.1M
- TERN 382.2M
- IPO Year
- ACNB N/A
- TERN 2021
- Fundamental
- Price
- ACNB $39.92
- TERN $4.45
- Analyst Decision
- ACNB Buy
- TERN Buy
- Analyst Count
- ACNB 3
- TERN 5
- Target Price
- ACNB $45.00
- TERN $18.30
- AVG Volume (30 Days)
- ACNB 23.7K
- TERN 1.8M
- Earning Date
- ACNB 01-31-2025
- TERN 03-13-2025
- Dividend Yield
- ACNB 3.21%
- TERN N/A
- EPS Growth
- ACNB N/A
- TERN N/A
- EPS
- ACNB 3.44
- TERN N/A
- Revenue
- ACNB $106,401,000.00
- TERN N/A
- Revenue This Year
- ACNB N/A
- TERN N/A
- Revenue Next Year
- ACNB $20.49
- TERN N/A
- P/E Ratio
- ACNB $11.51
- TERN N/A
- Revenue Growth
- ACNB N/A
- TERN N/A
- 52 Week Low
- ACNB $30.24
- TERN $4.32
- 52 Week High
- ACNB $50.72
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- ACNB 44.26
- TERN 27.09
- Support Level
- ACNB $35.89
- TERN $4.38
- Resistance Level
- ACNB $39.67
- TERN $5.95
- Average True Range (ATR)
- ACNB 1.11
- TERN 0.29
- MACD
- ACNB 0.28
- TERN -0.09
- Stochastic Oscillator
- ACNB 77.68
- TERN 4.46
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.